Navigation Links
Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301)
Date:9/29/2011

hilanthropic resources to go directly to COG's worldwide team of researchers committed to turning new discoveries into better treatments.

About Apeiron (as of September 2011):

Apeiron is a privately financed biotech based in Vienna, Austria. Apeiron focuses on biological and immunological treatments against cancer and related conditions. Including the recently closed licence agreement for the phase III project Mab ch14.18/CHO (APN311), Apeiron's project portfolio consists of five projects under clinical evaluation, and four preclinical projects. Clinical projects include the immunocytokine hu14.18-IL2 (APN301) that is about to enter a phase II (for certain neuroblastoma patients) shortly and is also being clinically tested against melanoma. Also in clinical stage is a liposomal formulation of recombinant human Superoxide Dismutase (APN201) to prevent or treat skin damage due to radiation treatment in cancer. A further clinical project, recombinant human Angiotensin Converting Enzyme 2 (APN01), was licensed to GlaxoSmithKline early 2010. It is expected to commence a phase II study for the treatment of Acute Respiratory Distress Syndrome in the near future and has considerable potential in other disease areas. Apeiron is operational since 2006 and employs approx. 25 people.

About APN301:

APN301 (hu14.18-IL2) is a recombinant fusion protein that consists of the humanized 14.18 monoclonal antibody, which recognizes the GD2 disialoganglioside, strongly expressed on virtually all cases of human neuroblastoma, as well as on several other human cancer types (including melanoma, small cell lung carcinoma, osteosarcoma, and soft-tissue sarcoma), linked genetically to human recombinant interleukin-2 (IL2) lymphokine. IL2 has been tested extensively in clinical cancer trials and is approved as an immune activator with documented anti-tumor effects in certain cancers (melanoma and renal cell cancer).

In patients, hu14.18-IL2 localizes to GD2-po
'/>"/>

SOURCE APEIRON Biologics AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. XECAN and Trimble Partner to Deliver ThingMagic Powered RFID Oncology Solution
2. Champions Oncology Clarifies Misstatements in News Article
3. Medicare HIT Incentive Update for the Oncology Practice - Free Educational Webinar
4. Champions Oncology Reports Full Year 2011 Financial Results
5. McKesson Specialty Care Solutions
6. US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work
7. Genentech and Novartis Remain Image Leaders in Oncology and Hematology
8. Oncology National Commercial (ONC) Study Outlines 10 Trends Shaping the Market for Oncology Pharmaceutical and Biotech Products
9. Reportlinker Adds Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
10. Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting
11. Beardsworth Continues to Strengthen Oncology Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... the basis of psychiatric disorders has been extremely challenging ... risk but are insufficient to cause disease. Now investigators ... Press journal Cell Stem Cell describe a ... risks interact with other risk factors or environmental exposures ... research pinpoints a genetic variant that may predispose individuals ...
(Date:7/10/2014)... RICHLAND, Wash. The lithium-ion batteries that power our ... run longer on a single charge with the help ... the porous material to replace the graphite traditionally used ... more than 10 times the energy storage capacity of ... lithium-ion battery electrode was published today in Nature ...
(Date:7/10/2014)... shelled out for crude 3-D glasses, polarized glasses, ... These basic devices, used to trick the brain ... be rendered obsolete with the introduction of new ... , TAU doctoral students Yuval Yifat, Michal Eitan, ... based on nanoantennas that could be used for ...
(Date:7/10/2014)... new alliance will see the two universities and NPL ... with business and industry and their complementary academic strengths., ... help to shape the scientific priorities of the UK. ... up to 300 high-calibre PhD students, will provide a ... NPL, the potential of the Laboratory will be grown ...
Breaking Biology Technology:New strategy could uncover genes at the root of psychiatric illnesses 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 2Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 3
... DRRX ) announced today that James E. ... NewsMakers in the Biotech Industry Investment,Conference to be ... 2007 at 11:30 a.m.,Eastern Time. (Logo: ... the presentation will be available by accessing,DURECT,s homepage ...
... Text provides cardiologists with an overview of cardiovascular genetics ... ... TORONTO, Aug. 29 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN),a ... and staging of virtually any disease or medical,condition, today announced ...
... Pharmaceuticals,Inc. (Amex: ANX ) a biopharmaceutical research ... for the treatment,of cancer and infectious diseases, announced ... is scheduled to present at the 2007,Thomas Weisel ... 1:30 p.m. Eastern Daylight Time. The conference takes ...
Cached Biology Technology:GeneNews' Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book 2ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference 2
(Date:7/11/2014)... burning in eastern New South Wales, Australia when NASA,s ... 03:35 UTC on July 11 (12:35 p.m. local time/11:35 ... eastern New South Wales (NSW), the Moderate Resolution Imaging ... the region and spotted smoke (light brown) from various ... are outlined in red. , The New South Wales, ...
(Date:7/11/2014)... USC Stem Cell scientists have set a "mouse TRAP" ... described by a recent study published in the ... line uses a technique called TRAP to extract cellular ... , Invented by scientists at the Rockefeller Institute for ... tag to the protein-making machinery, or ribosomes, of the ...
(Date:7/11/2014)... from the Max Planck Institute for Medical Research in ... understanding photosynthesis, the process by which the Earth first ... and which is therefore crucial for all higher forms ... the first direct visualization of a crucial event in ... specific protein complex, photosystem II, splits water into hydrogen ...
Breaking Biology News(10 mins):A first direct glimpse of photosynthesis in action 2
... of earth scientists report movement of warmed sea water through ... is greater than that off midocean volcanic ridges. The finding ... once considered barren. With about 71 percent of the ... under the sea, its geology, and the life it supports. ...
... German . Scientists at the Max ... have decoded the genome of the Pristionchus pacificus nematode, ... their work, which has been published in the latest ... Professor Ralf J. Sommer,s department in Tbingen have shown ...
... UC Davis researchers have defined a cellular process ... found an important starting point for identifying and ... rheumatoid arthritis, cardiovascular disease and some cancers. ... sPLA2-IIA binds to two integrins labeled alpha-V-beta-3 and ...
Cached Biology News:Ocean floor geysers warm flowing sea water 2Insight into the evolution of parasitism 2Insight into the evolution of parasitism 3UC Davis researchers discover new drug target for inflammatory disease 2
... The GSTTag Monoclonal Antibody is ... high affinity to the 26 kDa ... . This purified antibody is suitable ... GSTTag sequence expressed in E. coli ...
... LNA microarray slides for microRNA expression ... incorporate Exiqons unique Locked Nucleic Acid (LNA) ... mismatch discrimination for short microRNA (miRNA) targets. ... 1 g total RNA (no need for ...
... many modifications to the original formulas in efforts ... play an important role in tissue,culture. A salt ... osmotic balance in the medium and to provide ... is as valuable today as when it was ...
Imject Freund's Complete Adjuvant (FCA)...
Biology Products: